Intec Pharma Ltd. (NTEC)
(Delayed Data from NSDQ)
$6.24 USD
+0.02 (0.32%)
Updated May 3, 2019 04:00 PM ET
After-Market: $6.27 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Indaptus Therapeutics, Inc. [NTEC]
Reports for Purchase
Showing records 1 - 20 ( 78 total )
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Recent Progress, But We Remain on the Sidelines; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
New Research Agreement Announced With Merck; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Funding Round Completed; 2Q20 Financial Results; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
1Q20 Financials Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Still Awaiting Clarity on a Second Act; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Novartis Drops Collaboration, as Expected; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Outlook Remains Uncertain; 3Q19 Financials; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2Q19 Financial Results Reported; Route Ahead Remains Unclear; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ACCORDANCE Study Fails to Meet Primary or Secondary Endpoints; Downgrading to Neutral Without Target Price
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Accordion Pill Multiple-Dose Pharmacokinetic Data Presented at Parkinson''s Disease Conference; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
1Q19 Financial Results Reported; ACCORDANCE Top-Line Data Approaching; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Indaptus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Cannabis - Where are we and where are we going?
Provider: Edison Investment Research Limited
Analyst: JACOBS M